CD8A and non-small cell lung carcinoma: Similarly, Turk et al. [38] reported that DTX increased the number of CD4+ and CD8+ T cells, whereas Li et al. reported that treatment with DTX reduced the number of Tregs, increased the secretion of INF-γ and lowered that of TGF-β in non-small cell lung carcinoma [39].